InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by WENTWORTH KORY JAMES, Chief Financial Officer. Insider active across 1 companies, notably Entrada Therapeutics, Inc.. Cumulatively, 3 filings have been logged. Total volume traded: €56k. The latest transaction was filed on 1 April 2026 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
US$27,9322,500 shares@ US$11.17290.011% mcap100.0% of flow
Common Stock
SEC:0001725663-26-000005·
€27,9322,500 shares@ €11.17290.011% mcap50.0% of flow
Common Stock
SEC:0001725663-26-000005:0·
011,006 shares0
Common Stock
SEC:0001104659-22-030004:0·
3 of 3 declarations
About WENTWORTH KORY JAMES
Kory James Wentworth is the Chief Financial Officer of Entrada Therapeutics, Inc. In this role, he oversees all financial operations of the company, including accounting and financial planning. Wentworth is responsible for managing financial resources and developing strategies to support the company's growth. His expertise in finance is essential for ensuring Entrada's financial health.
